# Bristol-Myers Squibb Company (BMY) — Q1-2025 Earnings Results

**Report date:** 2025-04-24 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q1-2025

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Up 0.33%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.80 | N/A | +19.52% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a positive outlook on the company's performance despite not providing specific guidance. They emphasized the strength of their product portfolio.

**Key quotes:**

> Management highlighted the strong performance in key therapeutic areas.

> They expressed confidence in the ongoing pipeline developments.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Bristol Myers Squibb's strong EPS performance indicates better-than-expected profitability, which contributed to a slight increase in stock price. However, the lack of revenue data and guidance may leave investors cautious. The stock's modest rise reflects investor sentiment following the earnings surprise.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q1-2025_